Biochemotherapy for advanced melanoma: maybe it is real.

Suppr

超能文献

作者信息

Khayat David, Bernard-Marty Chantal, Meric Jean-Baptiste, Rixe Olivier

出版信息

J Clin Oncol. 2002 May 15;20(10):2411-4. doi: 10.1200/JCO.2002.20.10.2411.

DOI:10.1200/JCO.2002.20.10.2411

PMID:12011117

Abstract

摘要

相似文献

Biochemotherapy for advanced melanoma: maybe it is real.

J Clin Oncol. 2002 May 15;20(10):2411-4. doi: 10.1200/JCO.2002.20.10.2411.

Systemic chemotherapy in the treatment of malignant melanoma.

Expert Opin Pharmacother. 2003 Dec;4(12):2205-11. doi: 10.1517/14656566.4.12.2205.

Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy.

Semin Oncol. 1997 Feb;24(1 Suppl 4):S39-43.

[Treatment of metastasized malignant melanoma].

Praxis (Bern 1994). 2001 Mar 8;90(10):391-6.

[Chemotherapy of malignant melanoma].

Pol Arch Med Wewn. 1998 Oct;100(4):294-9.

Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanoma.

J Clin Oncol. 2009 Dec 20;27(36):6207-12. doi: 10.1200/JCO.2008.20.3075. Epub 2009 Nov 16.

Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2, granulocyte colony-stimulating factor, and tamoxifen for patients with metastatic melanoma.

J Clin Oncol. 1999 Sep;17(9):2752-61. doi: 10.1200/JCO.1999.17.9.2752.

Fatal malignant melanoma in an adolescent.

Pediatr Dermatol. 2010 Mar-Apr;27(2):201-3. doi: 10.1111/j.1525-1470.2010.01109.x.

Practical guidelines for the management of biochemotherapy-related toxicity in melanoma.

Clin Cancer Res. 2001 Sep;7(9):2611-9.

Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.

J Immunotoxicol. 2008 Apr;5(2):201-7. doi: 10.1080/15476910802131519.

引用本文的文献

TERT Promoter Mutations and Telomerase in Melanoma.

J Oncol. 2022 Jul 19;2022:6300329. doi: 10.1155/2022/6300329. eCollection 2022.

Extracellular Vesicles Shedding Promotes Melanoma Growth in Response to Chemotherapy.

Sci Rep. 2019 Oct 9;9(1):14482. doi: 10.1038/s41598-019-50848-z.

Accumulation of prohibitin is a common cellular response to different stressing stimuli and protects melanoma cells from ER stress and chemotherapy-induced cell death.

Oncotarget. 2017 Jun 27;8(26):43114-43129. doi: 10.18632/oncotarget.17810.

Cutaneous melanoma: new advances in treatment.

An Bras Dermatol. 2014 Mar-Apr;89(2):301-10. doi: 10.1590/abd1806-4841.20142540.

Circulating melanoma cells in the diagnosis and monitoring of melanoma: an appraisal of clinical potential.

Mol Diagn Ther. 2014 Apr;18(2):175-83. doi: 10.1007/s40291-013-0071-2.

Clinical features of malignant melanoma of the finger and therapeutic efficacies of different treatments.

Oncol Lett. 2011 Sep 1;2(5):811-815. doi: 10.3892/ol.2011.324. Epub 2011 Jun 10.

Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology Group.

J Cancer Res Clin Oncol. 2007 Jul;133(7):437-44. doi: 10.1007/s00432-006-0182-9. Epub 2007 Mar 3.

Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients.

Cancer Res. 2006 Jun 15;66(12):6111-7. doi: 10.1158/0008-5472.CAN-05-4198.

Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.

J Clin Oncol. 2005 Dec 20;23(36):9351-8. doi: 10.1200/JCO.2005.02.9876.

Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.

J Clin Oncol. 2005 Nov 1;23(31):8057-64. doi: 10.1200/JCO.2005.02.0958.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验